UBS AM’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.14M | Buy |
131,124
+35,735
| +37% | +$1.13M | ﹤0.01% | 1794 |
|
|
2025
Q1 | $3.17M | Buy |
95,389
+33,058
| +53% | +$1.1M | ﹤0.01% | 1787 |
|
|
2024
Q4 | $2.14M | Buy |
62,331
+678
| +1% | +$23.3K | ﹤0.01% | 2002 |
|
|
2024
Q3 | $2.47M | Sell |
61,653
-6,719
| -10% | -$269K | ﹤0.01% | 1932 |
|
|
2024
Q2 | $2.06M | Buy |
68,372
+31,593
| +86% | +$953K | ﹤0.01% | 1979 |
|
|
2024
Q1 | $1.24M | Hold |
36,779
| – | – | ﹤0.01% | 1909 |
|
|
2023
Q4 | $1.19M | Sell |
36,779
-1,713
| -4% | -$55.3K | ﹤0.01% | 1936 |
|
|
2023
Q3 | $1.26M | Buy |
38,492
+25,873
| +205% | +$848K | ﹤0.01% | 1831 |
|
|
2023
Q2 | $412K | Hold |
12,619
| – | – | ﹤0.01% | 2380 |
|
|
2023
Q1 | $412K | Sell |
12,619
-18,481
| -59% | -$603K | ﹤0.01% | 2380 |
|
|
2022
Q4 | $1.71M | Buy |
31,100
+6,308
| +25% | +$348K | ﹤0.01% | 1597 |
|
|
2022
Q3 | $1.1M | Buy |
24,792
+7,209
| +41% | +$319K | ﹤0.01% | 1909 |
|
|
2022
Q2 | $858K | Hold |
17,583
| – | – | ﹤0.01% | 2052 |
|
|
2022
Q1 | $855K | Buy |
17,583
+5,559
| +46% | +$270K | ﹤0.01% | 2220 |
|
|
2021
Q4 | $513K | Buy |
+12,024
| New | +$513K | ﹤0.01% | 2551 |
|